SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001479290-17-000042
Filing Date
2017-11-03
Accepted
2017-11-03 16:28:54
Documents
65
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rvncq31710q.htm 10-Q 1120353
2 EXHIBIT 10.1 rvnc-q317exhibit101.htm EX-10.1 34683
3 EXHIBIT 31.1 rvnc-q317exhibit311.htm EX-31.1 13583
4 EXHIBIT 31.2 rvnc-q317exhibit312.htm EX-31.2 13480
5 EXHIBIT 32.1 rvnc-q317exhibit321.htm EX-32.1 6250
6 EXHIBIT 32.2 rvnc-q317exhibit322.htm EX-32.2 6275
  Complete submission text file 0001479290-17-000042.txt   4862172

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rvnc-20170930.xml EX-101.INS 951964
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rvnc-20170930.xsd EX-101.SCH 39805
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rvnc-20170930_cal.xml EX-101.CAL 61184
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rvnc-20170930_def.xml EX-101.DEF 162261
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rvnc-20170930_lab.xml EX-101.LAB 465119
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rvnc-20170930_pre.xml EX-101.PRE 275400
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36297 | Film No.: 171176795
SIC: 2834 Pharmaceutical Preparations